Technical Analysis for AUPH - Aurinia Pharmaceuticals Inc

Grade Last Price % Change Price Change
grade A 14.84 2.34% 0.34
AUPH closed up 2.34 percent on Wednesday, April 8, 2020, on 52 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Up
Historical AUPH trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Bearish Engulfing Bearish 2.34%
Stochastic Sell Signal Bearish 2.34%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.34%
Outside Day Range Expansion 2.34%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, is engaged in the development of a therapeutic drug to treat autoimmune diseases in Canada. The company's lead drug includes Voclosporin, a calcineurin inhibitor for the treatment of lupus nephritis. It has a development and license agreement with 3SBio Inc. for the clinical development, registration, and commercialization of voclosporin in China; and licensing and collaboration agreement with Vifor Pharma for the treatment of lupus and various proteinuric nephrology indications. The company was formerly known as Isotechnika Pharma Inc. and changed its name to Aurinia Pharmaceuticals Inc. in October 2013. Aurinia Pharmaceuticals Inc. was founded in 1993 and is headquartered in Victoria, Canada.
Medicine Biopharmaceutical Life Sciences Drugs Autoimmune Diseases Immunosuppressants Peptides Lupus Lupus Nephritis Treatment Of Lupus

Is AUPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 21.93
52 Week Low 3.52
Average Volume 1,628,380
200-Day Moving Average 10.91
50-Day Moving Average 16.45
20-Day Moving Average 13.48
10-Day Moving Average 14.49
Average True Range 1.12
ADX 21.68
+DI 17.46
-DI 19.38
Chandelier Exit (Long, 3 ATRs ) 13.06
Chandelier Exit (Short, 3 ATRs ) 13.20
Upper Bollinger Band 15.92
Lower Bollinger Band 11.03
Percent B (%b) 0.78
BandWidth 36.22
MACD Line -0.38
MACD Signal Line -0.73
MACD Histogram 0.3447
Fundamentals Value
Market Cap 1.24 Billion
Num Shares 83.5 Million
EPS -1.30
Price-to-Earnings (P/E) Ratio -11.42
Price-to-Sales 1112.47
Price-to-Book 2.62
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.53
Resistance 3 (R3) 15.48 15.20 15.42
Resistance 2 (R2) 15.20 15.02 15.23 15.38
Resistance 1 (R1) 15.02 14.92 15.11 15.07 15.34
Pivot Point 14.74 14.74 14.79 14.77 14.74
Support 1 (S1) 14.56 14.56 14.65 14.61 14.34
Support 2 (S2) 14.28 14.46 14.31 14.30
Support 3 (S3) 14.10 14.28 14.27
Support 4 (S4) 14.15